Drug profile · INN
diphenidol hydrochloride
VONTROL
diphenidol hydrochloride (VONTROL) is a muscarinic acetylcholine receptor m1 antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — diphenidol hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
diphenidol hydrochloride (VONTROL) is a muscarinic acetylcholine receptor m1 antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M1 antagonist
Primary target: Muscarinic acetylcholine receptor M1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is diphenidol hydrochloride?
diphenidol hydrochloride (VONTROL) is a muscarinic acetylcholine receptor m1 antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for diphenidol hydrochloride?
VONTROL is a marketed brand name for diphenidol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diphenidol hydrochloride?
diphenidol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.